Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Lycopene In Preventing of Prostate Cancer Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about Lycopene In Preventing of Prostate Cancer conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Lycopene In Preventing of Prostate Cancer Clinical research trials and Lycopene In Preventing of Prostate Cancer health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Lycopene In Preventing of Prostate Cancer. Lycopene In Preventing of Prostate Cancer Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a Lycopene In Preventing of Prostate Cancer clinical trial. Human subjects often get the best healthcare possible for their Lycopene In Preventing of Prostate Cancer condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.

Home > "L" Clinical Trials Conditions > Lycopene In Preventing of Prostate Cancer

Lycopene In Preventing of Prostate Cancer



Lycopene In Preventing of Prostate Cancer

For Condition: Prostate Cancer
Status: Recruiting
Sponsor(s): University of Illinois , National Cancer Institute (NCI)
Synopsis: RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. The use of lycopene may be an effective way to prevent prostate cancer. PURPOSE: Phase I trial to study the effectiveness of lycopene in preventing prostate cancer.
Details: OBJECTIVES: - Determine any dose limiting toxicities and the maximum tolerated dose of lycopene administered orally as a food based delivery system in healthy male subjects 18-45 years of age for the chemoprevention of prostate cancer. - Determine the pharmacokinetics of this regimen in this population. - Determine the dose range of this regimen to be used in the 3 month multiple dose study, based on the toxicity, pharmacokinetics and feasibility resulting from the present study in this population. OUTLINE: This is a dose-escalation study. Patients receive a single dose of oral lycopene in a mixture of tomato paste, water, and olive oil over 15 minutes on day 1. Patients are asked to maintain a diet that contains negligible carotinoid for 28 days. Cohorts of 5 patients receive escalating doses of lycopene until the maximum tolerated dose (MTD) is determined. The MTD is defined as the dose preceding that at which 2 of 5 patients experience dose limiting toxicities. Patients are followed weekly for 4 weeks. PROJECTED ACCRUAL: A total of 5-25 patients will be accrued for this study.
Eligibility:
Study Type:  Interventional, Prevention
Minimum Age/Maximum Age: 18 Years/45 Years
Genders: Both
Protocol Entry Criteria: DISEASE CHARACTERISTICS: - Normal healthy males judged to be in good medical condition based on history and physical exam confirming the absence of chronic medical conditions - Baseline serum lycopene less than 600 nM PATIENT CHARACTERISTICS: Age: - 18 to 45 Performance status: - Karnofsky 100% Life expectancy: - Not specified Hematopoietic: - Hematologic function normal Hepatic: - Liver function normal - No hepatic disease Renal: - Kidney function normal - No renal disease Cardiovascular: - No hypertension requiring medication - No cardiovascular disease - Normal EKG Other: - No evidence of a psychiatric disorder - Must be within 15% of ideal body weight based on standard weight tables - No history of smoking within the past 3 months - At least 72 hours since prior alcohol consumption and no history of alcohol abuse - No history of gastrointestinal malabsorption or any other condition that could affect drug absorption - No allergy to tomato based products - No active malignancy at any site - No illness that would pose a threat or additional risk (e.g., thyroid disease, diabetes mellitus) PRIOR CONCURRENT THERAPY: Biologic therapy: - Not specified Chemotherapy: - Not specified Endocrine therapy: - Not specified Radiotherapy: - Not specified Surgery: - Not specified Other: - At least 14 days since prior prescription drugs - No concurrent regular prescription medications - At least 30 days since other prior experimental drugs - No concurrent participation in any other experimental trial
Total Enrollment: 

Location and Contact Information:

Overall Study Official:
KeithRodvold,  Study Chair,  University of Illinois

University of Illinois at Chicago Health Sciences Center *Recruiting*
Chicago,  Illinois,  60612
United States
Recruiting Keith  Rodvold 312-996-3341


Additional Information:
Study ID Numbers:  CDR0000067915;  UIC-N01-CN-85081,NCI-P00-0143,UIC-H-99-058
Study Start Date: 
Record last reviewed: September 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00006078

Other Prostate Cancer Studies:
1. Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain

2. A Phase I Study To Test The Safety Of DAVANAT With and Without 5-Fluorouracil In Patients With Solid Tumors

3. Selenium and Vitamin E in Preventing Prostate Cancer

4. Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods

5. ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

Related Studies:

Other Prostate Cancer Clinical Trials
Other Illinois Clinical Trials
Other Chicago Clinical Trials

Lycopene In Preventing of Prostate Cancer
Modify your Search

  Other Prostate Cancer Clinical Trials
  Other Illinois Clinical Trials
  Other Chicago Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103